Literature DB >> 308081

Activation of a human T cell subpopulation bearing receptors for autologous erythrocytes by concanavalin A.

C Fournier, J Charreire.   

Abstract

Human lymphocytes from different lymphoid organs were examined for rosette formation with autologous erythrocytes. The autorosette-forming cells (A-RFC) were shown to belong to a T cell subset including less mature lymphocytes. When normal human peripheral blood lymphocytes were stimulated with low doses of the plant lectin concanavalin A (Con A), in the presence of autologous plasma, the A-RFC levels were strongly enhanced. This response gave rise to two peaks: the first one coincided with the peak of thymidine incorporation but the maximum increase occurred 5 or 6 days later when the proliferative response was impaired. Depletion of A-RFC before stimulation with Con A led to a clear-cut decrease in autorosette levels at both peaks of the response. It is concluded that Con A, generally used for polyclonal activation against heteroantigens, may also result, in terms of A-RFC marker, in expansion of an autoreactive T cell population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308081

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.

Authors:  B Pautard; J J Rémy; J Charreire
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

2.  Characterization of human peripheral blood T lymphocytes bearing receptors for autologous erythrocytes and T lymphocytes lacking these receptors.

Authors:  T Sakane; M Honda; Y Taniguchi; H Kotani; Y Niwa
Journal:  J Clin Immunol       Date:  1982-01       Impact factor: 8.317

3.  Autologous rosette-forming T cells regulate responses of T cells. Phenotypic and functional analysis of suppressor cells generated from autologous rosette-forming T cells after autologous mixed lymphocyte reactions.

Authors:  S Kumagai; I Scher; I Green
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

4.  Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.

Authors:  A G Bird; L Hammarström; C I Smith; S Britton
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Separation of concanavalin A-induced human suppressor and helper T cells by the autologous erythrocyte rosette technique.

Authors:  T Sakane; M Honda; Y Taniguchi; H Kotani
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

6.  Human post-thymic precursor cells in health and disease. I. Characterization of the autologous rosette-forming T cells as post-thymic precursors.

Authors:  R Palacios; D Alarcón-Segovia; L Llorente; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

7.  Induction of human autorosette forming cells by phorbol myristate acetate.

Authors:  T Sakano; S Hyodo; E Kittaka; Y Tanaka; T Usui
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

8.  Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.

Authors:  S Hyodo; T Kishi; E Kittaka; T Suzawa; A Tanabe; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

9.  Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.

Authors:  S Takada; Y Ueda; Y Murakawa; N Suzuki; T Sakane
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

10.  Effects of tunicamycin and various monosaccharides on phytohaemagglutinin-induced autorosette formation.

Authors:  S Hyodo; T Kishi; H Kashiwa; E Kittaka; T Suzawa; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.